Organisation paid for research Program year 2024 Source: CMS Open Payments

Woolfson Eye Institute

Neither a doctor nor a teaching hospital

Research payments

$27,338

5 payments

Through program year 2024, Woolfson Eye Institute is reported as receiving $27,338 in research payments, across 5 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$6,000	3
2023	Research	$4,050	1
2022	Research	$17,288	1

Breakdown

Who paid Research payments · program years 2022–2024

Novartis Pharmaceuticals Corporation $21,338 2 payments
RxSight Inc $6,000 3 payments

Studies the money was for Research payments · program years 2022–2024

A 12-Week Parallel Group, Randomized, Placebo-Controlled, Double-Blinded, Multi-Center Study to Evaluate Efficacy and Safety of 2 Concentrations of Saf312 Eye Drops (5 MG/ML and 15 MG/ML) Used Twice-Daily in the Treatment of Post-Operative Corneal Induced $17,288 1 payment
Pmcs-002 $6,000 3 payments
A 12-Week Parallel Group, Randomized, Placebo-Controlled, Double-Blinded, Multi-Center Study to Evaluate Efficacy and Safety of 2 Concentrations of Saf312 Eye Drops (5 MG/ML and 15 MG/ML) Used Twice-Daily in the Treatment of Post-Operative Corneal Induced Chronic Pain (Cicp) Following Photorefractive Keratectomy (PRK) Or Laser-Assisted in Situ Keratomileusis (Lasik) Surgeries $4,050 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.